Key clinical point: Donor centers must be aware that some HIV-negative donors may pose risk of HIV breakthrough infections.
Major finding: Of 1494 samples from HIV-negative donors, 0.6% tested positive for pre-exposure prophylaxis drugs.
Study details: Study of blood samples from 299 HIV-positive attempted blood donors and 300 infection-negative donors.
Disclosures: TTIMS is supported by the FDA, NHLBI, and US Office of the Assistant Secretary for Health. Dr. Custer and all co-authors reported no relevant disclosures.
Custer BS. AABB 2019, Abstract PL5-MN4-32.